Sunho Biologics, Inc. (HKG:2898)
Hong Kong · Delayed Price · Currency is HKD 6.39
+0.04 (0.63%)
Feb 12, 2026, 6:09 PM HKT
Sunho Biologics Market Cap
Sunho Biologics has a market cap or net worth of 970.43 million as of February 13, 2026. Its market cap has increased by 52.63% in one year.
Market Cap
970.43M
Enterprise Value
596.44M
Revenue
18.63K
Ranking
n/a
PE Ratio
n/a
Stock Price
6.39
Market Cap Chart
Since May 24, 2024, Sunho Biologics's market cap has decreased from 2.19B to 970.43M, a decrease of -55.64%. That is a compound annual growth rate of -37.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 970.43M | -3.77% |
| Dec 31, 2025 | 1.01B | 78.00% |
| Dec 31, 2024 | 566.51M | -74.10% |
| May 24, 2024 | 2.19B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CANbridge Pharmaceuticals | 1.50B |
| Shanghai Bio-heart Biological Technology | 1.45B |
| Wuhan YZY Biopharma | 1.40B |
| Kintor Pharmaceutical | 1.38B |
| Beijing Biostar Pharmaceuticals | 1.33B |
| 3D Medicines | 1.13B |
| Brii Biosciences | 1.11B |
| Transcenta Holding | 1.06B |